3.10
price down icon5.78%   -0.19
after-market Handel nachbörslich: 3.17 0.07 +2.26%
loading
Schlusskurs vom Vortag:
$3.29
Offen:
$3.275
24-Stunden-Volumen:
51,482
Relative Volume:
0.53
Marktkapitalisierung:
$198.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-19.06%
1M Leistung:
-37.50%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$3.0701
$3.45
1-Wochen-Bereich:
Value
$3.0701
$4.20
52-Wochen-Spanne:
Value
$2.32
$5.69

Wellgistics Health Inc Stock (WGRX) Company Profile

Name
Firmenname
Wellgistics Health Inc
Name
Telefon
1-843-302-1785
Name
Adresse
3000 BAYPORT DRIVE SUITE 950, TAMPA
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
WGRX's Discussions on Twitter

Vergleichen Sie WGRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Pharmaceutical Retailers icon
WGRX
Wellgistics Health Inc
3.10 198.95M 0 0 0 0.00
Pharmaceutical Retailers icon
WBA
Walgreens Boots Alliance Inc
10.87 9.43B 147.66B -8.64B -363.00M -10.01
Pharmaceutical Retailers icon
HITI
High Tide Inc
2.31 165.11M 376.07M -22.41M 18.73M -0.298
Pharmaceutical Retailers icon
PETS
Petmed Express Inc
3.16 62.38M 270.52M -6.08M 17.42M -0.2944
Pharmaceutical Retailers icon
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd
0.9337 13.97M 0 0 0 0.00

Wellgistics Health Inc Aktie (WGRX) Neueste Nachrichten

pulisher
Apr 19, 2025

Wellgistics Health Converts Debt into Common Stock - MSN

Apr 19, 2025
pulisher
Apr 18, 2025

CEO of Wellgistics Health converts $1.5M of debt to equity at IPO price - MSN

Apr 18, 2025
pulisher
Apr 18, 2025

Wellgistics Health (WGRX) Shares Regain Ground In Extended Session - Stocks Telegraph

Apr 18, 2025
pulisher
Apr 15, 2025

Wellgistics Health converts debt to shares, CEO commits to hold By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Wellgistics Health Converts $1.5 Million Owed to CEO Into Equity at IPO Price - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Wellgistics Health converts debt to shares, CEO commits to hold - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price - Corsicana Daily Sun

Apr 15, 2025
pulisher
Apr 11, 2025

Wellgistics Health Acquires Peek Healthcare Technologies - TipRanks

Apr 11, 2025
pulisher
Apr 10, 2025

Wellgistics Health acquires Peek to broaden digital pharmacy By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Wellgistics Health to acquire Peek Healthcare Technologies - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

Wellgistics Health to Acquire Peek Healthcare Technologies - MarketScreener

Apr 10, 2025
pulisher
Apr 10, 2025

Wellgistics Health acquires Peek to broaden digital pharmacy - Investing.com Australia

Apr 10, 2025
pulisher
Apr 10, 2025

Wellgistics Health to acquire Peek Healthcare Technologies, terms not disclosed - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue - voiceofalexandria.com

Apr 10, 2025
pulisher
Mar 27, 2025

Wellgistics Health Expands with AI and Public Transition - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Wellgistics Health shares annual letter to shareholders - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025 - The Manila Times

Mar 27, 2025
pulisher
Mar 24, 2025

Why Retail Traders Are Rushing Into Small-Cap Wellgistics Health Weeks After Its Nasdaq Debut - Asianet Newsable

Mar 24, 2025
pulisher
Mar 21, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Wellgistics Health, Inc. Rings the Opening Bell - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Wellgistics Health, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

What is the future of healthcare in the US? - Fox Business

Mar 20, 2025
pulisher
Mar 18, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Enhancing Security For Pharmacy Solutions - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Wellgistics Health achieves SOC 2 Type 1 compliance - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Enhancing Commitment to Data Security and Regulatory Standards - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models - The Manila Times

Mar 18, 2025
pulisher
Mar 06, 2025

Form 424B3 Wellgistics Health, Inc. - StreetInsider.com

Mar 06, 2025
pulisher
Mar 06, 2025

Wellgistics Health announces departure of CEO Tim Canning - MSN

Mar 06, 2025
pulisher
Mar 05, 2025

$68M Tampa health tech firm appoints new CEO - Business Observer

Mar 05, 2025
pulisher
Mar 05, 2025

Wellgistics Health Appoints Brian Norton to Succeed Tim Canning as CEO -March 05, 2025 at 04:40 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 04, 2025

Wellgistics Health Appoints Brian Norton CEO - citybiz

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health appoints Brian Norton as CEO - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim - EIN News

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health Partners With Protega Pharmaceuticals To Expand Education And Access To ROXYBOND - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics partners with Protega to distribute opioid alternative By Investing.com - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

Protega Pharmaceuticals Collaborates With Wellgistics To Support Pharmacist Education - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics partners with Protega to distribute opioid alternative - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™ - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. and Protega Pharmaceuticals Collaborate to Enhance Access and Education for ROXYBOND™ Pain Management - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Protega collaborates with Wellgistics for Roxybond launch - The Pharma Letter

Mar 04, 2025
pulisher
Mar 03, 2025

Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™ - PR Newswire

Mar 03, 2025
pulisher
Feb 28, 2025

Wellgistics Health Expands with Tollo Health Partnership - TipRanks

Feb 28, 2025
pulisher
Feb 26, 2025

Wellgistics Health (NASDAQ:WGRX) Gaining First Mover Advantage in Untapped GLP-1 and Long Covid Markets - Insider Financial

Feb 26, 2025
pulisher
Feb 26, 2025

Wellgistics Expands Partnership With Tollo Health To Market Medical Foods For GLP-1, Long COVID - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market - The Manila Times

Feb 26, 2025

Finanzdaten der Wellgistics Health Inc-Aktie (WGRX)

Es liegen keine Finanzdaten für Wellgistics Health Inc (WGRX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$2.31
price up icon 0.00%
$3.16
price up icon 2.27%
$0.9337
price up icon 2.98%
$0.839
price down icon 3.31%
pharmaceutical_retailers SSY
$0.938
price up icon 3.51%
Kapitalisierung:     |  Volumen (24h):